Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients
Conferences
Tremblay, D; Ko, A; Chrysafi, P; How, C-J; Zon, R; Houghton, D; Ghorbanzadeh, A; Sastow, D; Alladi, SS; Georgen, M; Prabhu, A; Pachpande, V ...
Published in: Blood
November 3, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 3, 2025
Volume
146
Issue
Supplement 1
Start / End Page
1026 / 1026
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tremblay, D., Ko, A., Chrysafi, P., How, C.-J., Zon, R., Houghton, D., … Lauw, M. (2025). Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients. In Blood (Vol. 146, pp. 1026–1026). American Society of Hematology. https://doi.org/10.1182/blood-2025-1026
Tremblay, Douglas, Amica Ko, Pavlina Chrysafi, Chi-Joan How, Rebecca Zon, Damon Houghton, Atefeh Ghorbanzadeh, et al. “Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients.” In Blood, 146:1026–1026. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-1026.
Tremblay D, Ko A, Chrysafi P, How C-J, Zon R, Houghton D, et al. Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients. In: Blood. American Society of Hematology; 2025. p. 1026–1026.
Tremblay, Douglas, et al. “Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 1026–1026. Crossref, doi:10.1182/blood-2025-1026.
Tremblay D, Ko A, Chrysafi P, How C-J, Zon R, Houghton D, Ghorbanzadeh A, Sastow D, Alladi SS, Georgen M, Prabhu A, Pachpande V, Valisekka SS, Jahagirdar B, Kapoor S, Peseski A, Gangaraju R, Desai R, Zheng G, Dalmia S, Bhagirath V, Iurlo A, Cattaneo D, Guglielmelli P, Vannucchi A, Boldrini V, De Stefano V, Betti S, Rossi E, Ageno W, Berry J, Maffioli M, Agarwal M, Nayak AR, Dhawan R, Chiasakul T, Sanfilippo K, Hobbs G, Hoffman R, Baumann Kreuziger L, Patell R, Beckman J, Lauw M. Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients. Blood. American Society of Hematology; 2025. p. 1026–1026.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 3, 2025
Volume
146
Issue
Supplement 1
Start / End Page
1026 / 1026
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology